| Financial Year |
March 31 2023 |
| Monetary Funds |
12,431,100,282.26 |
| Held-for-trading Financial Assets |
350,540,022.77 |
| Notes Receivable |
22,232,533.37 |
| Accounts Receivable |
11,389,813,306.60 |
| Advances to Suppliers |
215,943,195.87 |
| Other Receivables |
100,956,209.07 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
12,781,884,092.02 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
220,585,774.58 |
| Other Current Assets |
570,726,948.55 |
| Total Current Assets |
38,095,956,694.44 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
954,168,556.00 |
| Investment Properties |
-- |
| Fixed Assetes |
21,044,469,745.58 |
| Under-construction Projects |
2,738,892,775.48 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
2,674,146,258.44 |
| R&D expenses |
348,216,002.08 |
| Goodwill |
16,859,185.08 |
| Long-Term Deferred and Prepaid Expenses |
337,073,218.29 |
| Deferred Income Tax Assets |
1,589,903,655.33 |
| Other Non-Current Assets |
889,784,167.66 |
| Sub-Total of Non-Current Assets |
32,150,154,747.81 |
| Total Assets |
70,246,111,442.25 |
| Short-Term Loans |
8,263,223,781.78 |
| Trading Financial liabilities |
48,571,656.01 |
| Notes Payable |
4,651,512,892.79 |
| Accounts Payable |
16,934,563,714.12 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
461,181,828.18 |
| Taxes Payable |
71,342,360.88 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
75,472,434.72 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
586,698,792.42 |
| Other Current Liabilities |
4,411,883.35 |
| Sub-Total of Current Liabilities |
33,783,342,334.78 |
| Long-term Loans |
3,469,528,252.81 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
863,445,795.86 |
| Other Non-Current Liabilities |
249,674,489.21 |
| Sub-Total of Non-Current Liabilities |
5,547,139,285.56 |
| Total Liabilities |
39,330,481,620.34 |
| Paid-In Capital(Or Share Stock) |
3,420,403,200.00 |
| Capital Surplus |
9,033,890,583.28 |
| Surplus Reserve |
1,446,536,121.51 |
| LESS:Treasury Stock |
470,343,148.41 |
| Undistributed Profits |
16,615,726,723.42 |
| Minority Stockholder's Interest |
770,024,518.52 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
30,145,605,303.39 |
| Owner's Equity（Stockholder's Equity） |
30,915,629,821.91 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
70,246,111,442.25 |
